SEARCH

SEARCH BY CITATION

References

  • Allen, J.E., Hough, R.E., Goepel, J.R., Bottomley, S., Wilson, G.A., Alcock, H.E., Baird, M., Lorigan, P.C., Vandenberghe, E.A., Hancock, B.W. & Hammond, D.W. (2002) Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. British Journal of Haematology, 116, 291298.
  • Andersen, N.S., Jensen, M.K., De Nully Brown, P. & Geisler, C.H. (2002) A Danish population-based analysis of 105 mantle cell lymphoma patients. Incidences, clinical features, response, survival and prognostic factors. European Journal of Cancer, 38, 401408.
  • Angelopoulou, M.K., Siakantariz, M.P., Vassilakopoulos, T.P., Kontopidou, F.N., Rassidakis, G.Z., Dimopoulou, M.N., Kittas, C. & Pangalis, G.A. (2002) The splenic form of mantle cell lymphoma. European Journal of Haematology, 68, 1221.
  • Argatoff, L.H., Connors, J.M., Klasa, R.J., Horsman, D.E. & Gascoyne, R.D. (1997) Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood, 89, 20672078.
  • Babbage, G., Garand, R., Robillard, N., Zojer, N., Stevenson, F.K. & Sahota, S.S. (2004) Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events. Blood, 103, 27952798.
  • Bea, S., Ribas, M., Hernandez, J.M., Bosch, F., Pinyol, M., Hernandez, L., Garcia, J.L., Flores, T., Gonzalez, M., Lopez-Guillermo, A., Piris, M.A., Cardesa, A., Montserrat, E., Miro, R. & Campo, E. (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood, 93, 43654374.
  • Bea, S., Tort, F., Pinyol, M., Puig, X., Hernandez, L., Hernandez, S., Fernandez, P.L., Van Lohuizen, M., Colomer, D. & Campo, E. (2001) BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Research, 61, 24092412.
  • Bentz, M., Plesch, A., Bullinger, L., Stilgenbauer, S., Ott, G., Muller-Hermelink, H.K., Baudis, M., Barth, T.F., Moller, P., Lichter, P. & Dohner, H. (2000) t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes, Chromosomes & Cancer, 27, 285294.
  • Betticher, D.C., Thatcher, N., Altermatt, H.J., Hoban, P., Ryder, W.D. & Heighway, J. (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 11, 10051011.
  • De Boer, C.J., Schuuring, E., Dreef, E., Peters, G., Bartek, J., Kluin, P.M. & Van Krieken, J.H. (1995) Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood, 86, 27152723.
  • De Boer, C.J., Vaandrager, J.W., Van Krieken, J.H., Holmes, Z., Kluin, P.M. & Schuuring, E. (1997) Visualization of mono-allelic chromosomal aberrations 3′ and 5′ of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization. Oncogene, 15, 15991603.
  • Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., Tassies, D., Jaffe, E.S., Montserrat, E., Rozman, C. & Cardesa, A. (1994) PRAD-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood, 84, 27262732.
  • Bosch, F., Lopez-Guillermo, A., Campo, E., Ribera, J.M., Conde, E., Piris, M.A., Vallespi, T., Woessner, S. & Montserrat, E. (1998) Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer, 82, 567575.
  • Brody, J. & Advani, R. (2006) Treatment of mantle cell lymphoma: current approach and future directions. Critical Reviews in Oncology/Hematology, 58, 257265.
  • Camacho, E., Hernandez, L., Hernandez, S., Tort, F., Bellosillo, B., Bea, S., Bosch, F., Montserrat, E., Cardesa, A., Fernandez, P.L. & Campo, E. (2002) ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood, 99, 238244.
  • Camacho, F.I., Algara, P., Rodriguez, A., Ruiz-Ballesteros, E., Mollejo, M., Martinez, N., Martinez-Climent, J.A., Gonzalez, M., Mateo, M., Caleo, A., Sanchez-Beato, M., Menarguez, J., Garcia-Conde, J., Sole, F., Campo, E. & Piris, M.A. (2003) Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood, 101, 40424046.
  • Camacho, F.I., Garcia, J.F., Cigudosa, J.C., Mollejo, M., Algara, P., Ruiz-Ballesteros, E., Gonzalvo, P., Martin, P., Perez-Seoane, C., Sanchez-Garcia, J. & Piris, M.A. (2004) Aberrant Bcl6 protein expression in mantle cell lymphoma. American Journal of Surgical Pathology, 28, 10511056.
  • Camacho, E., Bea, S., Salaverria, I., Lopez-Guillermo, A., Puig, X., Benavente, Y., De Sanjose, S., Campo, E. & Hernandez, L. (2006) Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma. International Journal of Cancer, 118, 357363.
  • Campo, E., Raffeld, M. & Jaffe, E.S. (1999) Mantle-cell lymphoma. Seminars in Hematology, 36, 115127.
  • Carreras, J., Villamor, N., Colomo, L., Moreno, C., Cajal, S., Crespo, M., Tort, F., Bosch, F., Lopez-Guillermo, A., Colomer, D., Montserrat, E. & Campo, E. (2005) Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. Journal of Pathology, 205, 507513.
  • Carrere, N., Belaud-Rotureau, M.A., Dubus, P., Parrens, M., De Mascarel, A. & Merlio, J.P. (2005) The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism. Haematologica, 90, 854856.
  • Chiarle, R., Budel, L.M., Skolnik, J., Frizzera, G., Chilosi, M., Corato, A., Pizzolo, G., Magidson, J., Montagnoli, A., Pagano, M., Maes, B., De Wolf-Peeters, C. & Inghirami, G. (2000) Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood, 95, 619626.
  • Clodi, K., Snell, V., Zhao, S., Cabanillas, F., Andreeff, M. & Younes, A. (1998) Unbalanced expression of Fas and CD40 in mantle cell lymphoma. British Journal of Haematology, 103, 217219.
  • Cogliatti, S.B., Bertoni, F., Zimmermann, D.R., Henz, S., Diss, T.C., Ghielmini, M. & Schmid, U. (2005) IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome. Journal of Pathology, 206, 320327.
  • Coqueret, O. (2002) Linking cyclins to transcriptional control. Gene, 299, 3555.
  • Corradini, P., Dodero, A., Farina, L., Fanin, R., Patriarca, F., Miceli, R., Matteucci, P., Bregni, M., Scime, R., Narni, F., Pogliani, E., Locasciulli, A., Milani, R., Carniti, C., Bacigalupo, A., Rambaldi, A., Bonifazi, F., Olivieri, A., Gianni, A.M. & Tarella, C. (2007) Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome. Leukemia, 21, 23162323.
  • Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marce, S., Lopez-Guillermo, A., Campo, E. & Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine, 348, 17641775.
  • De Jong, D., Rosenwald, A., Chhanabhai, M., Gaulard, P., Klapper, W., Lee, A., Sander, B., Thorns, C., Campo, E., Molina, T., Norton, A., Hagenbeek, A., Horning, S., Lister, A., Raemaekers, J., Gascoyne, R.D., Salles, G. & Weller, E. (2007) Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. Journal of Clinical Oncology, 25, 805812.
  • Dono, M., Cerruti, G. & Zupo, S. (2004) The CD5+ B-cell. International Journal of Biochemistry and Cell Biology, 36, 21052111.
  • Dreyling, M.H., Bullinger, L., Ott, G., Stilgenbauer, S., Muller-Hermelink, H.K., Bentz, M., Hiddemann, W. & Dohner, H. (1997) Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Research, 57, 46084614.
  • Dreyling, M., Lenz, G., Hoster, E., Van Hoof, A., Gisselbrecht, C., Schmits, R., Metzner, B., Truemper, L., Reiser, M., Steinhauer, H., Boiron, J.M., Boogaerts, M.A., Aldaoud, A., Silingardi, V., Kluin-Nelemans, H.C., Hasford, J., Parwaresch, R., Unterhalt, M. & Hiddemann, W. (2005) Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood, 105, 26772684.
  • Espinet, B., Sole, F., Pedro, C., Garcia, M., Bellosillo, B., Salido, M., Florensa, L., Camacho, F.I., Baro, T., Lloreta, J. & Serrano, S. (2005) Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Human Pathology, 36, 12321237.
  • Fang, N.Y., Greiner, T.C., Weisenburger, D.D., Chan, W.C., Vose, J.M., Smith, L.M., Armitage, J.O., Mayer, R.A., Pike, B.L., Collins, F.S. & Hacia, J.G. (2003) Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 100, 53725377.
  • Fernandez, V., Jares, P., Bea, S., Salaverria, I., Guino, E., De Sanjose, S., Colomer, D., Ott, G., Montserrat, E. & Campo, E. (2004) Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica, 89, 13221331.
  • Fernandez, V., Hartmann, E., Ott, G., Campo, E. & Rosenwald, A. (2005) Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. Journal of Clinical Oncology, 23, 63646369.
  • Ferrer, A., Salaverria, I., Bosch, F., Villamor, N., Rozman, M., Bea, S., Gine, E., Lopez-Guillermo, A., Campo, E. & Montserrat, E. (2007) Leukemic involvement is a common feature in mantle cell lymphoma. Cancer, 109, 24732480.
  • Ferrer, A., Bosch, F., Villamor, N., Rozman, M., Graus, F., Gutierrez, G., Mercadal, S., Campo, E., Rozman, C., Lopez-Guillermo, A. & Montserrat, E. (2008) Central nervous system involvement in mantle cell lymphoma. Annals of Oncology, 19, 135141.
  • Fitzgibbon, J., Smith, L.L., Raghavan, M., Smith, M.L., Debernardi, S., Skoulakis, S., Lillington, D., Lister, T.A. & Young, B.D. (2005) Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Research, 65, 91529154.
  • Flordal, T.E., Ichimura, K., Collins, V.P., Walsh, S.H., Barbany, G., Hagberg, A., Laurell, A., Rosenquist, R., Larsson, C. & Lagercrantz, S. (2007) Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma. Leukemia Research, 31, 12271238.
  • Forstpointner, R., Dreyling, M., Repp, R., Hermann, S., Hanel, A., Metzner, B., Pott, C., Hartmann, F., Rothmann, F., Rohrberg, R., Bock, H.P., Wandt, H., Unterhalt, M. & Hiddemann, W. (2004) The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood, 104, 30643071.
  • Forstpointner, R., Unterhalt, M., Dreyling, M., Bock, H.P., Repp, R., Wandt, H., Pott, C., Seymour, J.F., Metzner, B., Hanel, A., Lehmann, T., Hartmann, F., Einsele, H. & Hiddemann, W. (2006) Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). Blood, 108, 40034008.
  • Fu, K., Weisenburger, D.D., Greiner, T.C., Dave, S., Wright, G., Rosenwald, A., Chiorazzi, M., Iqbal, J., Gesk, S., Siebert, R., De, J.D., Jaffe, E.S., Wilson, W.H., Delabie, J., Ott, G., Dave, B.J., Sanger, W.G., Smith, L.M., Rimsza, L., Braziel, R.M., Muller-Hermelink, H.K., Campo, E., Gascoyne, R.D., Staudt, L.M. & Chan, W.C. (2005) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood, 106, 43154321.
  • Fu, L., Lin-Lee, Y.C., Pham, L.V., Tamayo, A., Yoshimura, L. & Ford, R.J. (2006) Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood, 107, 45404548.
  • Gesk, S., Klapper, W., Martin-Subero, J.I., Nagel, I., Harder, L., Fu, K., Bernd, H.W., Weisenburger, D.D., Parwaresch, R. & Siebert, R. (2006) A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood, 108, 11091110.
  • Gianni, A.M., Magni, M., Martelli, M., Di, N.M., Carlo-Stella, C., Pilotti, S., Rambaldi, A., Cortelazzo, S., Patti, C., Parvis, G., Benedetti, F., Capria, S., Corradini, P., Tarella, C. & Barbui, T. (2003) Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood, 102, 749755.
  • Gladden, A.B., Woolery, R., Aggarwal, P., Wasik, M.A. & Diehl, J.A. (2006) Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene, 25, 9981007.
  • Gong, J.Z., Lagoo, A.S., Peters, D., Horvatinovich, J., Benz, P. & Buckley, P.J. (2001) Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Clinical Pathology, 116, 893897.
  • Goy, A., Younes, A., McLaughlin, P., Pro, B., Romaguera, J.E., Hagemeister, F., Fayad, L., Dang, N.H., Samaniego, F., Wang, M., Broglio, K., Samuels, B., Gilles, F., Sarris, A.H., Hart, S., Trehu, E., Schenkein, D., Cabanillas, F. & Rodriguez, A.M. (2005) Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 23, 667675.
  • Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R. & Weisenburger, D.D. (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood, 87, 43024310.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 18481854.
  • Hangaishi, A., Ogawa, S., Qiao, Y., Wang, L., Hosoya, N., Yuji, K., Imai, Y., Takeuchi, K., Miyawaki, S. & Hirai, H. (2002) Mutations of Chk2 in primary hematopoietic neoplasms. Blood, 99, 30753077.
  • Harbour, J.W. & Dean, D.C. (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes and Development, 14, 23932409.
  • Haritunians, T., Mori, A., O’Kelly, J., Luong, Q.T., Giles, F.J. & Koeffler, H.P. (2007) Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma. Leukemia, 21, 333339.
  • Hartmann, E., Fernandez, V., Stoecklein, H., Hernandez, L., Campo, E. & Rosenwald, A. (2007) Increased MDM2 expression is associated with inferior survival in mantle cell lymphoma, but not related to the MDM2 SNP309. Haematologica, 92, 574575.
  • Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F., Peinado, M.A., Piris, M.A., Montserrat, E., Cardesa, A., Jaffe, E.S., Campo, E. & Raffold, M. (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood, 87, 33513359.
  • Hernandez, L., Bea, S., Pinyol, M., Ott, G., Katzenberger, T., Rosenwald, A., Bosch, F., Lopez-Guillermo, A., Delabie, J., Colomer, D., Montserrat, E. & Campo, E. (2005) CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Cancer Research, 65, 21992206.
  • Hirt, C., Schuler, F., Dolken, L., Schmidt, C.A. & Dolken, G. (2004) Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood, 104, 904905.
  • Hoffman, D.G., Tucker, S.J., Emmanoulides, C., Rosen, P.A. & Naeim, F. (1998) CD8-positive mantle cell lymphoma: a report of two cases. American Journal of Clinical Pathology, 109, 689694.
  • Hoster, E., Dreyling, M., Klapper, W., Gisselbrecht, C., Van Hoof, A., Kluin-Nelemans, H.C., Pfreundschuh, M., Reiser, M., Metzner, B., Einsele, H., Peter, N., Jung, W., Wormann, B., Ludwig, W.D., Duhrsen, U., Eimermacher, H., Wandt, H., Hasford, J., Hiddemann, W. & Unterhalt, M. (2008) A new prognostic index (MIPI) for patients with advanced stage mantle cell lymphoma. Blood, 111, 558565.
  • Howe, D. & Lynas, C. (2001) The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica, 86, 563569.
  • Hultdin, M., Rosenquist, R., Thunberg, U., Tobin, G., Norrback, K.F., Johnson, A., Sundstrom, C. & Roos, G. (2003) Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. British Journal of Cancer, 88, 593598.
  • Hummel, M., Tamaru, J., Kalvelage, B. & Stein, H. (1994) Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood, 84, 403407.
  • Hutter, G., Scheubner, M., Zimmermann, Y., Kalla, J., Katzenberger, T., Hubler, K., Roth, S., Hiddemann, W., Ott, G. & Dreyling, M. (2006) Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Genes Chromosomes & Cancer, 45, 203210.
  • Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A. & Van Lohuizen, M. (1999) The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164168.
  • Jares, P., Campo, E., Pinyol, M., Bosch, F., Miquel, R., Fernandez, P.L., Sanchez-Beato, M., Soler, F., Perez-Losada, A., Nayach, I., Mallofre, C., Piris, M.A., Montserrat, E. & Cardesa, A. (1996) Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. American Journal of Pathology, 148, 15911600.
  • Jares, P., Colomer, D. & Campo, E. (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nature Reviews Cancer, 7, 750762.
  • Karnan, S., Tagawa, H., Suzuki, R., Suguro, M., Yamaguchi, M., Okamoto, M., Morishima, Y., Nakamura, S. & Seto, M. (2004) Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization. Genes, Chromosomes & Cancer, 39, 7781.
  • Katzenberger, T., Petzoldt, C., Holler, S., Mader, U., Kalla, J., Adam, P., Ott, M.M., Muller-Hermelink, H.K., Rosenwald, A. & Ott, G. (2006) The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood, 107, 3407.
  • Khouri, I.F., Lee, M.S., Saliba, R.M., Jun, G., Fayad, L., Younes, A., Pro, B., Acholonu, S., McLaughlin, P., Katz, R.L. & Champlin, R.E. (2003) Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma. Journal of Clinical Oncology, 21, 44074412.
  • Khoury, J.D., Medeiros, L.J., Rassidakis, G.Z., McDonnell, T.J., Abruzzo, L.V. & Lai, R. (2003) Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression. Journal of Pathology, 199, 9097.
  • Kienle, D., Krober, A., Katzenberger, T., Ott, G., Leupolt, E., Barth, T.F., Moller, P., Benner, A., Habermann, A., Muller-Hermelink, H.K., Bentz, M., Lichter, P., Dohner, H. & Stilgenbauer, S. (2003) VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood, 102, 30033009.
  • Kienle, D., Katzenberger, T., Ott, G., Saupe, D., Benner, A., Kohlhammer, H., Barth, T.F., Holler, S., Kalla, J., Rosenwald, A., Muller-Hermelink, H.K., Moller, P., Lichter, P., Dohner, H. & Stilgenbauer, S. (2007) Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors. Journal of Clinical Oncology, 25, 27702777.
  • Knudsen, K.E., Diehl, J.A., Haiman, C.A. & Knudsen, E.S. (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 25, 16201628.
  • Kohlhammer, H., Schwaenen, C., Wessendorf, S., Holzmann, K., Kestler, H.A., Kienle, D., Barth, T.F., Moller, P., Ott, G., Kalla, J., Radlwimmer, B., Pscherer, A., Stilgenbauer, S., Dohner, H., Lichter, P. & Bentz, M. (2004) Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood, 104, 795801.
  • Kouroukis, C.T., Belch, A., Crump, M., Eisenhauer, E., Gascoyne, R.D., Meyer, R., Lohmann, R., Lopez, P., Powers, J., Turner, R. & Connors, J.M. (2003) Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology, 21, 17401745.
  • Kramer, A., Schweizer, S., Neben, K., Giesecke, C., Kalla, J., Katzenberger, T., Benner, A., Muller-Hermelink, H.K., Ho, A.D. & Ott, G. (2003) Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin’s lymphoma. Leukemia, 17, 22072213.
  • Kuppers, R. & Dalla-Favera, R. (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene, 20, 55805594.
  • LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. & Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes and Development, 11, 847862.
  • Lenz, G., Dreyling, M., Hoster, E., Wormann, B., Duhrsen, U., Metzner, B., Eimermacher, H., Neubauer, A., Wandt, H., Steinhauer, H., Martin, S., Heidemann, E., Aldaoud, A., Parwaresch, R., Hasford, J., Unterhalt, M. & Hiddemann, W. (2005) Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). Journal of Clinical Oncology, 23, 19841992.
  • Lim, M.S., Adamson, A., Lin, Z., Perez-Ordonez, B., Jordan, R.C., Tripp, S., Perkins, S.L. & Elenitoba-Johnson, K.S. (2002) Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index. Blood, 100, 29502956.
  • Lovec, H., Grzeschiczek, A., Kowalski, M.-B. & Moroy, T. (1994) Cyclin D1/bcl-1 cooperates with myc genes in the generation of B- cell lymphomas in transgenic mice. EMBO Journal, 13, 34873495.
  • Majlis, A., Pugh, W.C., Rodriguez, M.A., Benedict, W.F. & Cabanillas, F. (1997) Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. Journal of Clinical Oncology, 15, 16641671.
  • Maris, M.B., Sandmaier, B.M., Storer, B.E., Chauncey, T., Stuart, M.J., Maziarz, R.T., Agura, E., Langston, A.A., Pulsipher, M., Storb, R. & Maloney, D.G. (2004) Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood, 104, 35353542.
  • Martinez, N., Camacho, F.I., Algara, P., Rodriguez, A., Dopazo, A., Ruiz-Ballesteros, E., Martin, P., Martinez-Climent, J.A., Garcia-Conde, J., Menarguez, J., Solano, F., Mollejo, M. & Piris, M.A. (2003) The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival. Cancer Research, 63, 82268232.
  • Marzec, M., Kasprzycka, M., Lai, R., Gladden, A.B., Wlodarski, P., Tomczak, E., Nowell, P., Deprimo, S.E., Sadis, S., Eck, S., Schuster, S.J., Diehl, J.A. & Wasik, M.A. (2006) Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood, 108, 17441750.
  • Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J.A., Siebert, R., Climent, J., Fresquet, V., Beltran, E., Agirre, X., Marugan, I., Marin, M., Rosenwald, A., Sugimoto, K.J., Wheat, L.M., Karran, E.L., Garcia, J.F., Sanchez, L., Prosper, F., Staudt, L.M., Pinkel, D., Dyer, M.J. & Martinez-Climent, J.A. (2007) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood, 109, 271280.
  • Montagnoli, A., Fiore, F., Eytan, E., Carrano, A.C., Draetta, G.F., Hershko, A. & Pagano, M. (1999) Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes and Development, 13, 11811189.
  • Montserrat, E., Bosch, F., Lopez-Guillermo, A., Graus, F., Terol, M.J., Campo, E. & Rozman, C. (1996) CNS involvement in mantle-cell lymphoma. Journal of Clinical Oncology, 14, 941944.
  • Nagy, B., Lundan, T., Larramendy, M.L., Aalto, Y., Zhu, Y., Niini, T., Edgren, H., Ferrer, A., Vilpo, J., Elonen, E., Vettenranta, K., Franssila, K. & Knuutila, S. (2003) Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma. British Journal of Haematology, 120, 434441.
  • Nakamura, N., Kuze, T., Hashimoto, Y., Tasaki, K., Hojo, H., Sasaki, Y., Sato, M. & Abe, M. (1999) Analysis of the immunoglobulin heavy chain gene variable region of 101 cases with peripheral B cell neoplasms and B cell chronic lymphocytic leukemia in the Japanese population. Pathology International, 49, 595600.
  • Neben, K., Ott, G., Schweizer, S., Kalla, J., Tews, B., Katzenberger, T., Hahn, M., Rosenwald, A., Ho, A.D., Muller-Hermelink, H.K., Lichter, P. & Kramer, A. (2007) Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma. International Journal of Cancer, 120, 16691677.
  • Nielaender, I., Martin-Subero, J.I., Wagner, F., Martinez-Climent, J.A. & Siebert, R. (2006) Partial uniparental disomy: a recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia, 20, 904905.
  • Nodit, L., Bahler, D.W., Jacobs, S.A., Locker, J. & Swerdlow, S.H. (2003) Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Human Pathology, 34, 10301034.
  • Norton, A.J., Matthews, J., Pappa, V., Shamash, J., Love, S., Rohatiner, A.Z.S. & Lister, T.A. (1995) Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Annals of Oncology, 6, 249256.
  • O’connor, O.A., Wright, J., Moskowitz, C., Muzzy, J., Gregor-Cortelli, B., Stubblefield, M., Straus, D., Portlock, C., Hamlin, P., Choi, E., Dumetrescu, O., Esseltine, D., Trehu, E., Adams, J., Schenkein, D. & Zelenetz, A.D. (2005) Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin’s lymphoma and mantle cell lymphoma. Journal of Clinical Oncology, 23, 676684.
  • Oinonen, R., Franssila, K., Teerenhovi, L., Lappalainen, K. & Elonen, E. (1998) Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients. European Journal of Cancer, 34, 329336.
  • Orchard, J., Garand, R., Davis, Z., Babbage, G., Sahota, S., Matutes, E., Catovsky, D., Thomas, P.W., Avet-Loiseau, H. & Oscier, D. (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood, 101, 49754981.
  • Ott, G., Kalla, J., Ott, M.M., Schryen, B., Katzenberger, T., Muller, J.G. & Muller-Hermelink, H.K. (1997) Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood, 89, 14211429.
  • Peponi, E., Drakos, E., Reyes, G., Leventaki, V., Rassidakis, G.Z. & Medeiros, L.J. (2006) Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. American Journal of Pathology, 169, 21712180.
  • Perkins, E.J., Nair, A., Cowley, D.O., Van Dyke, T., Chang, Y. & Ramsden, D.A. (2002) Sensing of intermediates in V(D)J recombination by ATM. Genes and Development, 16, 159164.
  • Pham, L.V., Tamayo, A.T., Yoshimura, L.C., Lo, P. & Ford, R.J. (2003) Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. Journal of Immunology, 171, 8895.
  • Pinyol, M., Hernandez, L., Cazorla, M., Balbin, M., Jares, P., Fernandez, P.L., Montserrat, E., Cardesa, A., Lopez-Otin, C. & Campo, E. (1997) Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood, 89, 272280.
  • Pinyol, M., Hernandez, L., Martinez, A., Cobo, F., Hernandez, S., Bea, S., Lopez-Guillermo, A., Nayach, I., Palacin, A., Nadal, A., Fernandez, P.L., Montserrat, E., Cardesa, A. & Campo, E. (2000) INK4a/ARF locus alterations in human non-Hodgkin’s lymphomas mainly occur in tumors with wild-type p53 gene. American Journal of Pathology, 156, 19871996.
  • Pinyol, M., Salaverria, I., Bea, S., Fernandez, V., Colomo, L., Campo, E. & Jares, P. (2006) Unbalanced expression of licensing DNA replication factors occurs in a subset of mantle cell lymphomas with genomic instability. International Journal of Cancer, 119, 27682774.
  • Pinyol, M., Bea, S., Pla, L., Ribrag, V., Bosq, J., Rosenwald, A., Campo, E. & Jares, P. (2007) Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood, 109, 54225429.
  • Pittaluga, S., Verhoef, G., Criel, A., Maes, A., Nuyts, J., Boogaerts, M. & De Wolf Peeters, C. (1996) Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leukemia & Lymphoma, 21, 115125.
  • Pittaluga, S., Tierens, A., Pinyol, M., Campo, E., Delabie, J. & De Wolf-Peeters, C. (1998) Blastic variants of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. British Journal of Haematology, 102, 13011306.
  • Quintanilla-Martinez, L., Thieblemont, C., Fend, F., Kumar, S., Pinyol, M., Campo, E., Jaffe, E.S. & Raffeld, M. (1998) Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. American Journal of Pathology, 153, 175182.
  • Quintanilla-Martinez, L., Davies-Hill, T., Fend, F., Calzada-Wack, J., Sorbara, L., Campo, E., Jaffe, E.S. & Raffeld, M. (2003) Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood, 101, 31813187.
  • Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. & Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New England Journal of Medicine, 351, 893901.
  • Rinaldi, A., Kwee, I., Taborelli, M., Largo, C., Uccella, S., Martin, V., Poretti, G., Gaidano, G., Calabrese, G., Martinelli, G., Baldini, L., Pruneri, G., Capella, C., Zucca, E., Cotter, F.E., Cigudosa, J.C., Catapano, C.V., Tibiletti, M.G. & Bertoni, F. (2006) Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. British Journal of Haematology, 132, 303316.
  • Rizzatti, E.G., Falcao, R.P., Panepucci, R.A., Proto-Siqueira, R., Anselmo-Lima, W.T., Okamoto, O.K. & Zago, M.A. (2005) Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. British Journal of Haematology, 130, 516526.
  • Romaguera, J.E., Medeiros, L.J., Hagemeister, F.B., Fayad, L.E., Rodriguez, M.A., Pro, B., Younes, A., McLaughlin, P., Goy, A., Sarris, A.H., Dang, N.H., Samaniego, F., Brown, H.M., Gagneja, H.K. & Cabanillas, F. (2003) Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer, 97, 586591.
  • Romaguera, J.E., Fayad, L., Rodriguez, M.A., Broglio, K.R., Hagemeister, F.B., Pro, B., McLaughlin, P., Younes, A., Samaniego, F., Goy, A., Sarris, A.H., Dang, N.H., Wang, M., Beasley, V., Medeiros, L.J., Katz, R.L., Gagneja, H., Samuels, B.I., Smith, T.L. & Cabanillas, F.F. (2005) High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. Journal of Clinical Oncology, 23, 70137023.
  • Rosenwald, A., Wright, G., Wiestner, A., Chan, W.C., Connors, J.M., Campo, E., Gascoyne, R.D., Grogan, T.M., Muller-Hermelink, H.K., Smeland, E.B., Chiorazzi, M., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Montserrat, E., Bosch, F., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Fisher, R.I., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L.M. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, 185197.
  • Roue, G., Perez-Galan, P., Lopez-Guerra, M., Villamor, N., Campo, E. & Colomer, D. (2007) Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level. Journal of Immunology, 178, 19231930.
  • Rubio-Moscardo, F., Blesa, D., Mestre, C., Siebert, R., Balasas, T., Benito, A., Rosenwald, A., Climent, J., Martinez, J.I., Schilhabel, M., Karran, E.L., Gesk, S., Esteller, M., DeLeeuw, R., Staudt, L.M., Fernandez-Luna, J.L., Pinkel, D., Dyer, M.J. & Martinez-Climent, J.A. (2005a) Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood, 106, 32143222.
  • Rubio-Moscardo, F., Climent, J., Siebert, R., Piris, M.A., Martin-Subero, J.I., Nielander, I., Garcia-Conde, J., Dyer, M.J., Terol, M.J., Pinkel, D. & Martinez-Climent, J.A. (2005b) Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood, 105, 44454454.
  • Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T.H., Fend, F., Jaffe, E.S., Quintanilla-Martinez, L. & Raffeld, M. (2006) Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood, 108, 16681676.
  • Rummel, M.J., De Vos, S., Hoelzer, D., Koeffler, H.P. & Hofmann, W.K. (2004) Altered apoptosis pathways in mantle cell lymphoma. Leukemia & Lymphoma, 45, 4954.
  • Salar, A., Juanpere, N., Bellosillo, B., Domingo-Domenech, E., Espinet, B., Seoane, A., Romagosa, V., Gonzalez-Barca, E., Panades, A., Pedro, C., Nieto, M., Abella, E., Sole, F., Ariza, A., Fernandez-Sevilla, A., Besses, C. & Serrano, S. (2006) Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. American Journal of Surgical Pathology, 30, 12741280.
  • Salaverria, I., Perez-Galan, P., Colomer, D. & Campo, E. (2006) Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica, 91, 1116.
  • Salaverria, I., Zettl, A., Bea, S., Moreno, V., Valls, J., Hartmann, E., Ott, G., Wright, G., Lopez-Guillermo, A., Chan, W.C., Weisenburger, D.D., Gascoyne, R.D., Grogan, T.M., Delabie, J., Jaffe, E.S., Montserrat, E., Muller-Hermelink, H.K., Staudt, L.M., Rosenwald, A. & Campo, E. (2007) Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. Journal of Clinical Oncology, 25, 12161222.
  • Samaha, H., Dumontet, C., Ketterer, N., Moullet, I., Thieblemont, C., Bouafia, F., Callet-Bauchu, E., Felman, P., Berger, F., Salles, G. & Coiffier, B. (1998) Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia, 12, 12811287.
  • Sander, B., Flygare, J., Porwit-MacDonald, A., Smith, C.I., Emanuelsson, E., Kimby, E., Liden, J. & Christensson, B. (2005) Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1. International Journal of Cancer, 117, 418430.
  • Schlette, E., Fu, K. & Medeiros, L.J. (2003) CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. American Journal of Clinical Pathology, 120, 760766.
  • Schrader, C., Meusers, P., Brittinger, G., Teymoortash, A., Siebmann, J.U., Janssen, D., Parwaresch, R. & Tiemann, M. (2004) Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Leukemia, 18, 12001206.
  • Schrader, C., Janssen, D., Klapper, W., Siebmann, J.U., Meusers, P., Brittinger, G., Kneba, M., Tiemann, M. & Parwaresch, R. (2005) Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. British Journal of Cancer, 93, 939945.
  • Schraders, M., Pfundt, R., Straatman, H.M., Janssen, I.M., Van Kessel, A.G., Schoenmakers, E.F., Van Krieken, J.H. & Groenen, P.J. (2005) Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood, 105, 16861693.
  • Schulz, H., Bohlius, J.F., Trelle, S., Skoetz, N., Reiser, M., Kober, T., Schwarzer, G., Herold, M., Dreyling, M., Hallek, M. & Engert, A. (2007) Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. Journal of the National Cancer Institute, 99, 706714.
  • Seto, M., Yamamoto, K., Iida, S., Akao, Y., Utsumi, K.R., Kubonishi, I., Miyoshi, I., Ohtsuki, T., Yawata, Y. & Namba, M. (1992) Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene, 7, 14011406.
  • Sherr, C.J. & Roberts, J.M. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development, 13, 15011512.
  • Solomon, D.A., Wang, Y., Fox, S.R., Lambeck, T.C., Giesting, S., Lan, Z., Senderowicz, A.M., Conti, C.J. & Knudsen, E.S. (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. Journal of Biological Chemistry, 278, 3033930347.
  • Stilgenbauer, S., Winkler, D., Ott, G., Schaffner, C., Leupolt, E., Bentz, M., Moller, P., Muller-Hermelink, H.K., James, M.R., Lichter, P. & Dohner, H. (1999) Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood, 94, 32623264.
  • Swerdlow, S.H., Berger, F., Isaacson, P., Muller-Hermelink, H.K., Nathwani, B.N., Piris, M.A. & Harris, N.L. (2001) Mantle cell lymphoma. In: World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and lymphoid Tissues (ed. by E.S.Jaffer, N.L.Harris, H.Stein & J.W.Vardiman), pp. 168170. IARC Press, Lyon.
  • Tagawa, H., Karnan, S., Suzuki, R., Matsuo, K., Zhang, X., Ota, A., Morishima, Y., Nakamura, S. & Seto, M. (2005) Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene, 24, 13481358.
  • Teramoto, N., Pokrovskaja, K., Szekely, L., Polack, A., Yoshino, T., Akagi, T. & Klein, G. (1999) Expression of cyclin D2 and D3 in lymphoid lesions. International Journal of Cancer, 81, 543550.
  • Thelander, E.F., Walsh, S.H., Thorselius, M., Laurell, A., Landgren, O., Larsson, C., Rosenquist, R. & Lagercrantz, S. (2005) Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes. Modern Pathology, 18, 331339.
  • Thorselius, M., Walsh, S., Eriksson, I., Thunberg, U., Johnson, A., Backlin, C., Enblad, G., Sundstrom, C., Roos, G. & Rosenquist, R. (2002) Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. European Journal of Haematology, 68, 217224.
  • Tiemann, M., Schrader, C., Klapper, W., Dreyling, M.H., Campo, E., Norton, A., Berger, F., Kluin, P., Ott, G., Pileri, S., Pedrinis, E., Feller, A.C., Merz, H., Janssen, D., Hansmann, M.L., Krieken, H., Moller, P., Stein, H., Unterhalt, M., Hiddemann, W. & Parwaresch, R. (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. British Journal of Haematology, 131, 2938.
  • Tort, F., Hernandez, S., Bea, S., Martinez, A., Esteller, M., Herman, J.G., Puig, X., Camacho, E., Sanchez, M., Nayach, I., Lopez-Guillermo, A., Fernandez, P.L., Colomer, D., Hernandez, L. & Campo, E. (2002) CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas. Blood, 100, 46024608.
  • Tort, F., Camacho, E., Bosch, F., Harris, N.L., Montserrat, E. & Campo, E. (2004) Familial lymphoid neoplasms in patients with mantle cell lymphoma. Haematologica, 89, 314319.
  • Tort, F., Hernandez, S., Bea, S., Camacho, E., Fernandez, V., Esteller, M., Fraga, M.F., Burek, C., Rosenwald, A., Hernandez, L. & Campo, E. (2005) Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leukemia, 19, 112117.
  • Vaandrager, J.W., Schuuring, E., Zwikstra, E., De Boer, C.J., Kleiverda, K.K., Van Krieken, J.H., Kluin-Nelemans, H.C., Van Ommen, G.J., Raap, A.K. & Kluin, P.M. (1996) Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood, 88, 11771182.
  • Viswanatha, D.S., Foucar, K., Berry, B.R., Gascoyne, R.D., Evans, H.L. & Leith, C.P. (2000) Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Modern Pathology, 13, 825833.
  • Walsh, S.H., Thorselius, M., Johnson, A., Soderberg, O., Jerkeman, M., Bjorck, E., Eriksson, I., Thunberg, U., Landgren, O., Ehinger, M., Lofvenberg, E., Wallman, K., Enblad, G., Sander, B., Porwit-MacDonald, A., Dictor, M., Olofsson, T., Sundstrom, C., Roos, G. & Rosenquist, R. (2003) Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood, 101, 40474054.
  • Weigert, O., Pastore, A., Rieken, M., Lang, N., Hiddemann, W. & Dreyling, M. (2007) Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma. Leukemia, 21, 524528.
  • Weisenburger, D.D., Vose, J.M., Greiner, T.C., Lynch, J.C., Chan, W.C., Bierman, P.J., Dave, B.J., Sanger, W.G. & Armitage, J.O. (2000) Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. American Journal of Hematology, 64, 190196.
  • Welzel, N., Le, T., Marculescu, R., Mitterbauer, G., Chott, A., Pott, C., Kneba, M., Du, M.Q., Kusec, R., Drach, J., Raderer, M., Mannhalter, C., Lechner, K., Nadel, B. & Jaeger, U. (2001) Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Research, 61, 16291636.
  • Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H.K., Ott, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Vose, J., Armitage, J.O., Gascoyne, R.D., Connors, J.M., Campo, E., Montserrat, E., Bosch, F., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Fisher, R.I., Grogan, T.M., Miller, T.P., Wilson, W.H., Jaffe, E.S. & Staudt, L.M. (2007) Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood, 109, 45994606.
  • Williams, M.E., Whitefield, M. & Swerdlow, S.H. (1997) Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia. Annals of Oncology, 8(Suppl. 2), 7173.
  • Xiong, Y., Connolly, T., Futcher, B. & Beach, D. (1991) Human D-type cyclin. Cell, 65, 691699.
  • Yin, C.C., Medeiros, L.J., Cromwell, C.C., Mehta, A.P., Lin, P., Luthra, R. & Abruzzo, L.V. (2007) Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Modern Pathology, 20, 17.
  • Zukerberg, L.R., Benedict, W.F., Arnold, A., Dyson, N., Harlow, E. & Harris, N.L. (1996) Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Blood, 88, 268276.